Flortaucipir: all 31 studies that test it
Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.
- A Phase I Study of [18F]Flortaucipir PET Imaging in Chinese Subjects: Safety, Pharmacokinetics, Biodistribution, Radiation Dosimetry, and Preliminary Diagnostic EfficacyRecruitingNCT07580703Phase 1
- Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's DiseaseRecruitingNCT03821857Phase 4
- Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal StudyRecruitingNCT02740634Not applicable
- A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear PalsyRecruitingNCT02605785Not applicable
- Longitudinal Multi-Modality Imaging in Progressive Apraxia of SpeechRecruitingNCT01818661Phase 4
- Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired SubjectsCompletedNCT04474405Early Phase 1Results posted
- Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's DiseaseCompletedNCT04468347Phase 1Results posted
- Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's DiseaseCompletedNCT03901105Phase 3Results posted
- A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan InterpretationCompletedNCT03901092Phase 3Results posted
- Tau Screening Study in Subjects With Early Symptomatic ADCompletedNCT03467477Phase 2Results posted
- Tau Screening Study in Patients With Early Symptomatic ADCompletedNCT03322462Phase 2Results posted
- Flortaucipir 18F PET Imaging in BIOCARD StudyTerminatedNCT03052972Phase 1Results posted
- Flortaucipir PET Imaging in Subjects With FTDCompletedNCT03040713Phase 1Results posted
- Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05CompletedNCT02795780Phase 2Results posted
- Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and Frontotemporal DementiaCompletedNCT02736695Phase 1Results posted
- Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT MutationsCompletedNCT02676843Phase 2Results posted
- 18F-AV-1451 Autopsy StudyCompletedNCT02516046Phase 3Results posted
- 18F-AV-1451 High Resolution Autopsy StudyCompletedNCT02350634Phase 1Results posted
- Augmenting Flortaucipir Dosimetry EstimatesCompletedNCT02336360Phase 1Results posted
- Clinical Evaluation of Flortaucipir F 18CompletedNCT02278367Phase 2Results posted
- Tau Imaging in Professional FightersCompletedNCT02278354Phase 1Results posted
- Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy VolunteersCompletedNCT02167594Phase 1Results posted
- 18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic EncephalopathyCompletedNCT02079766Phase 2Results posted
- Imaging Characteristics of a Follow-up 18F-AV-1451 ScanTerminatedNCT02051764Phase 2Results posted
- Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD SubjectsCompletedNCT02016560Phase 2/3Results posted
- A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired SubjectsCompletedNCT01992380Phase 1Results posted
- 18F-AV-1451 PET Imaging in Participants Enrolled in the LEARN StudyCompletedNCT02850146Phase 1
- F 18 T807 Tau PET Imaging of Frontotemporal Dementia (FTD)WithdrawnNCT02707978Phase 2
- 18F-AV-1451 PET Imaging in TBIWithdrawnNCT02512029Phase 1
- Quantitative Evaluation of [18F]T807 as a Potential PET Radioligand for Imaging Tau in Patients With Alzheimer's DiseaseCompletedNCT02370524Phase 1
- Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy SubjectsCompletedNCT02103894Phase 1